Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

Grass Pollen Allergy - Pipeline Review, H2 2013 - New Report Available


Print article Print article
2013-12-22 02:10:44 - New Pharmaceuticals market report from Global Markets Direct: "Grass Pollen Allergy - Pipeline Review, H2 2013"

Global Markets Direct's, 'Grass Pollen Allergy - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Grass Pollen Allergy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Grass Pollen Allergy. Grass Pollen Allergy - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of

data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Grass Pollen Allergy.
* A review of the Grass Pollen Allergy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Grass Pollen Allergy pipeline on the basis of route of administration and molecule type.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Full Report Details at
- www.fastmr.com/prod/755147_grass_pollen_allergy_pipeline_review_ ..

Reasons to Get this Report

* Identify and understand important and diverse types of therapeutics under development for Grass Pollen Allergy.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Grass Pollen Allergy pipeline depth and focus of Indication therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Companies Mentioned in this Report: ALK-Abello A/S, Allergy Therapeutics plc, Stallergenes S.A., Allergopharma Joachim Ganzer KG, Circassia Holdings Ltd., Laboratorios LETI S.L., ANERGIS SA, Bial - Portela & Ca, S.A., Biomay AG

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Grass Pollen Allergy Overview
Therapeutics Development
An Overview of Pipeline Products for Grass Pollen Allergy
Grass Pollen Allergy Therapeutics under Development by Companies
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Grass Pollen Allergy Therapeutics - Products under Development by Companies
Companies Involved in Grass Pollen Allergy Therapeutics Development
ALK-Abello A/S
Allergy Therapeutics plc
Stallergenes S.A.
Allergopharma Joachim Ganzer KG
Circassia Holdings Ltd.
Laboratorios LETI S.L.
ANERGIS SA
Bial - Portela & Ca, S.A.
Biomay AG
Grass Pollen Allergy - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
Pollinex Quattro Grass - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Pollinex Quattro Grass - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Allergen Extract Of Phleum Pratense - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Grass Pollen Allergoid - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Grass-SPIRE - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Grazax - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Grazax - Drug Profile
Product Description
Mechanism of Action
R&D Progress
gpASIT + TM - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Oralair - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Grass Allergen mRNA Vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
BM-32 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Grass Hypoallergenic Vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
AllerG - Drug Profile
Product Description
Mechanism of Action
R&D Progress
BIA-142954 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Grass Pollen Allergy Therapeutics - Drug Profile Updates
Grass Pollen Allergy Therapeutics - Dormant Products
Grass Pollen Allergy - Product Development Milestones
Featured News & Press Releases
Oct 23, 2013: FDA reschedules Advisory Committee meeting for grass AIT tablet
Oct 09, 2013: FDA postpones Allergenic Products Advisory Committee meeting for the 5 grass AIT tablet due to US government shutdown
Oct 08, 2013: FDA postpones Advisory Committee meeting for grass AIT tablet due to US government shutdown
Oct 01, 2013: Circassia's Rapid Grass Allergy Treatment Achieves Significant Symptom Reduction During Hay Fever Season
Mar 27, 2013: Merck Announces FDA Acceptance Of Biologics License Application For Investigational Grass Pollen Allergy Immunotherapy Tablet

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=755147&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com